MUMBAI, India, June 19 -- Intellectual Property India has published a patent application (202617056759 A) filed by Biohaven Therapeutics Ltd. on May 05, 2026, for Bispecific Molecular Degraders Of Pathogenic Proteins.
Inventors include Bunin, Anna; Car, Bruce; Dow, Megan; Gardin, Tova; Lipson, Sarah; Marcin, Lawrence R.; Mellott, Drake; Murray, Stewart; Pirman, David; and Velaparthi, Upender.
The application for the patent was published on June 05, 2026, under issue no. 23/2026.
Abstract: Provided are bispecific degraders of extracellular proteins, autoantibodies, anti-drug antibodies, and other related molecules, and methods of treatment of various diseases, disorders and medical conditions using such bispecific degraders. Wherein the bispecific degraders are comprised of a cellular receptor-binding moiety that can bind to hepatocytes or other degrading cells through asialoglycoprotein receptors (ASGPR) of hepatocytes or other cell receptors on the surface of hepatocytes or other degrading cells in a subject or patient, and a linker moiety connecting the target-binding moiety and the cellular receptor¬ binding moiety.
Disclaimer: Curated by HT Syndication.
